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Abstract
Background: Fine-needle aspiration biopsy has become the standard of care for the evaluation of thyroid nodules.
More recently, the use of ultrasound guided fine-needle aspiration biopsy (UG-FNAB) has improved adequacy
of sampling. Now there has been improved access to UG-FNAB as ultrasound technology has become more
accessible. Here we review the adequacy rate and learning curve of a single surgeon starting at the adoption
of UG-FNAB into surgical practice.
Methods: UG-FNABs performed at Sunnybrook Health Sciences Centre from 2010 to 2015 were reviewed
retrospectively. Nodule characteristics were recorded along with cytopathology and final pathology reports.
Chi-square analysis, followed by the reporting of odds ratios with confidence intervals, were used to assess the
statistical significance and frequencies, respectively, of nodule characteristics amongst both diagnostic and
non-diagnostic samples. A multiple regression analysis was conducted to determine if any nodule characteristic
were predictive of adequacy of UG-FNABs. The learning curve was assessed by calculating the eventual adequacy
rates across each year, and its statistical significance was measured using Fischer’s Exact Test.
Results: In total 423 biopsies were reviewed in 289 patients. The average nodule size was 23.05 mm. When
examining if each patient eventually received a diagnostic UG-FNAB, regardless of the number attempts,
adequacy was seen to increase from 70.8 % in 2010 to, 81.0 % in 2011, 90.3 % in 2012, 85.7 % in 2013, 89.7 %
in 2014, and 94.3 % in 2015 (Fischer’s Exact Test, p = 0.049). Cystic (χ2 = 19.70, p <0.001) nodules were found to
yield higher rates of non-diagnostic samples, and their absence are predictive of obtaining an adequate biopsy
as seen in a multiple regression analysis (p < 0.001) Adequacy of repeat biopsies following an initial non-diagnostic
sample was 75.0 %.
Conclusions: Surgeons are capable of performing UG-FNAB with a learning curve noted to achieve standard adequacy
rates. Cystic nodules are shown to yield more non-diagnostic samples in the surgeon’s office.
Keywords: Ultrasound-guided fine-needle aspiration biopsy, Surgeon preformed, Thyroid nodules, Cystic lesions,
Microcalcifications, Learning curve, Adequacy
* Correspondence: kevin.higgins@sunnybrook.ca
3Department of Otolaryngology–Head & Neck Surgery, University of Toronto,
Sunnybrook Health Sciences Centre, 2075 Bayview Avenue, Suite M1 102,
Toronto, ON M4N 3 M5, Canada
Full list of author information is available at the end of the article
© 2015 Fernandes et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Fernandes et al. Journal of Otolaryngology - Head and Neck Surgery
 (2015) 44:42 
DOI 10.1186/s40463-015-0099-x
Background
Fine needle aspirates (FNA) are the standard of care for
evaluating thyroid nodules. The use of FNA has de-
creased the percentage of surgical pathology specimens
containing only benign thyroid tissue, and therefore de-
creased the amount of unnecessary operations. While
historically these biopsies have been performed by palpa-
tion alone in the office, a shift toward biopsy under
ultrasound guidance has increased the adequacy rate of
biopsies to greater than 80 % [1–10]. With the increased
availability of ultrasound technology in the office setting,
head and neck surgeons and endocrinologists have
begun incorporating the tool into their practice.
Office-based ultrasound and biopsy offers several po-
tential benefits for patients. Although there is a paucity
of evidence examining the patient experience, it is intui-
tive that patients who are able to undergo an ultrasound
and biopsy at their surgeon’s office following recommen-
dation will wait less than those being referred to another
clinic for biopsy. Furthermore, patients undergoing sur-
veillance of thyroid nodules often have anxiety relating
to the lack of diagnosis with the nodule. Many patients
speak of the comfort they feel having their primary clin-
ician perform the ultrasound surveillance and biopsy
rather than a technologist or outside physician with
whom they have no ongoing clinical relationship. For
those previously biopsied benign nodules of large size,
the surgeon’s ability to survey them might reduce un-
necessary surgery and further decrease the rate of be-
nign pathology in surgical reports.
Previous studies have reported on the experience of
radiologists as well as patient wait times for surgery and
diagnostic accuracy for surgeon performed UG-FNABs.
However, here we report the largest Canadian series of
ultrasound-guided fine needle aspirate biopsies (UG-
FNAB) conducted by surgeons.
Methods
Patients
Consecutive patient charts were reviewed from 2010 to
2015. Charts were collated from a list created by the
Sunnybrook Health Sciences Centre (SHSC) otolaryn-
gology office manager of patients catalogued as having
undergone a thyroid biopsy with ultrasound guidance
in the department. This search yielded 652 individual
biopsies, which were then evaluated by a two re-
viewers. 229 charts were excluded: 38 had no ultra-
sound report available, 78 were not specifically thyroid
biopsies, 28 were found to be duplicates, 39 had no cy-
tology report available, and 46 were performed by a
different practitioner. This project was approved by the
Research Ethics Board of Sunnybrook Health Science
Centre (ID 169–2013).
Surgical technique
A Hitachi Aloka© ultrasound machine was used to per-
form a diagnostic ultrasound of both thyroid lobes and
the lateral neck. The principal investigator conducted all
UG-FNABs. Nodules with suspicious features were tar-
geted according to ATA guidelines. The patient was
placed in the supine position with a green towel placed
for semi sterile technique. A 10 MHz probe identified
the nodule, and using a 25 G needle nodules were tar-
geted using primarily the capillary suction technique
using multiple passes, and a combination of the short
and long axis techniques.
Data collection
Data extracted from patient charts included demographic
information, FNA cytology reports and pathology reports.
Adequacy of specimen and diagnosis was reported by the
cytopathologist at SHSC according to the Bethesda system
for reporting thyroid fine needle aspirate biopsy (FNAB).
Nodule characteristics were drawn from the ultrasound
procedure report.
Analysis
Statistical analysis was completed with SPSS® (V20,
IBM Corp ©). Statistical significance for all tests were
set at p < 0.05. Chi-square analysis, followed by the
reporting of odds ratios (OR) with confidence intervals
(CI), was used to assess the statistical significance and
measure of association, respectively, of nodule charac-
teristics amongst both diagnostic and non-diagnostic
samples. A multiple regression was conducted to deter-
mine if any nodule characteristic were predictive of ad-
equacy of UG-FNABs. The learning curve was assessed
by calculating the eventual adequacy rates across each
year, and its statistical significance was measured using
Fischer’s Exact Test. The outcomes were recorded starting
from the time at which the practice of using UG-FNAB
was adopted into clinical practice. A comprehensive re-
view of the North American and European English lan-
guage literature was performed with the assistance of
SHSC Librarians.
Results
In total, 423 separate biopsies were examined in 289 in-
dividuals. Subject characteristics are noted in Table 1.
Table 1 Subject characteristics




Nodule Size 23.05 mm (3.9–100) σ = 14.04
Adequacy 86.9 %
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The overall eventual adequacy rate was 86.8 %, which
means that 86.8 % of the patients across all years, re-
gardless of the number of biopsies, received a diagnostic
UG-FNAB. Figure 1 outlines the breakdown of cytopa-
thology reports according to Bethesda classification.
Amongst the non-diagnostic specimens, pathologists re-
ported that 14 (14.6 %) were due to blood, 14 (14.6 %)
were due to cyst contents, 36 (37.5 %) had no follicular
cells, and 32 (33.3 %) were reported as having limited
cellularity to make a diagnosis (Fig. 2).
There was no significant difference when adequacy
was contrasted in terms of internal vascularity, echotec-
ture, irregular margins, or microcalcifications in a chi-
square analysis. However, cystic lesions (Fig. 3) (χ2 = 19.70,
p < 0.001, OR = 3.21 CI: 1.89–5.43) were more commonly
found amongst non-diagnostic specimens. Furthermore,
a multivariate logistic regression was run to predict
UG-FNAB adequacy from nodule size, cystic nature,
echotexture, and the presence of microcalcifications.
These variables statistically significantly predicted adequacy
(χ2 = 15.71, p = 0.003, df = 4). However, Nagelkerke’s R2 of
0.091 shows that the independent variables were a poor
model for prediction of adequacy. Moreoever, only one
variable, cystic nature, added statistically significantly to
the prediction, p < 0.001. The results from the multiple re-
gression support those found in the chi-square analysis.
The learning curve was demonstrated sufficiently by
measuring the proportion of patients per annum who
eventually received a diagnostic UG-FNAB, regardless of
the number attempts. Eventual adequacy (Fig. 4) was
seen to increase from 70.8 % in 2010 to, 81.0 % in 2011,
90.3 % in 2012, 85.7 % in 2013, 89.7 % in 2014, and
94.3 % in 2015 (Fischer’s Exact Test, p = 0.032). Amongst
the UG-FNABs that were repeat biopsies following an
initial non-diagnostic sample, the subsequent adequacy
rate was 75.0 %, with an average of 12.4 days (n = 16)
between initial and repeat biopsies across all years.
Discussion
A review of surgeon-performed biopsies at Sunnybrook
Health Sciences Centre has demonstrated an overall
eventual adequacy rate of 86.9 %, with a clear learning
curve experienced as the eventual adequacy rate im-
proves each year, peaking at approximately 94.0 % in
2015. Our findings are consistent with the Canadian lit-
erature, which supports the association of cystic nodules
were associated with non-diagnostic specimens [11] and
shows that adequacy rates can approach 90 % [12].
Larger surgeon audits report overall adequacy rates of
70–92 % [1–4], while reports of radiologists, endocrinol-
ogists, and pathologists performing UG-FNABs suggest
adequacy rates varying from 67 % to 94 % [5–10]. The
current adequacy rate in our practice is comparable to
those available in the literature.
Our institution uses the Bethesda system to report
thyroid cytopathology [13]. The evidence reviewed at the
Bethesda meeting suggested that non-diagnostic rates
are between 2 and 20 %. Our data demonstrate that over
time the adequacy rate will approach acceptable rates in
a surgeon’s office, showing evidence of a learning curve.
To mitigate the impact of physician learning on patient















Fig. 1 Fine needle aspirate biopsies by Bethesda classification. Of all the biopsies taken with ultrasound guidance, 23.2 % yielded non-diagnostic
specimens, 59.1 % benign, 8.3 % were either follicular lesion of undetermined significance or atypia of undetermined significance, 1.9 % follicular adenoma,
2.4 % suspicious for malignancy and 5.2 % reported as malignancy
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sent to radiology for repeat biopsy. As time went on
and non-diagnostic rates diminished, this practice was
abandoned. A review of repeat biopsies following non-
diagnostic specimens in our centre demonstrated im-
proved adequacy up to 75.0 % overall with a second
biopsy. These figures are important, as the common
practice to send a patient for a radiologist performed
biopsy might increase the rate of lost-to follow up fol-
lowing non-diagnostic sampling, and certainly increases
wait times. At our institution, rather than wait 4–6
weeks for a radiologist appointment, patients have the
benefit of immediate biopsy at clinic visit. If repeat biopsy
is sought during a clinic visit in which non-diagnostic re-
sults are reviewed, that repeat biopsy can be performed
the same day.
Surgeon-performed ultrasound-guided fine needle as-
pirates has been adopted over the past decade in North
America. As more and more physicians adopt the prac-
tice, it is necessary to obtain quality measures to ensure










Fig. 2 Breakdown of reason given for a specimen being non-diagnostic. Of all the non-diagnostic biopsies, our cytopathologists commented that




























Fig. 3 Distribution of diagnostic and non-diagnostic UG-FNABs by presence of cystic lesions. This double bar graph represents the frequency of
diagnostic and non-diagnostic UG-FNABs when cystic components are absent or present in the biopsied nodule. In total, 383 biopsies reported the cystic
nature of the nodule; with 86 diagnostic and 39 non-diagnostic lesions with a cystic component; and 226 diagnostic and 32 non-diagnostic lesions
without a cystic component
Fernandes et al. Journal of Otolaryngology - Head and Neck Surgery  (2015) 44:42 Page 4 of 7
that must be understood in the adoption of a new pro-
cedure is the learning curve. The concept comes from
the engineering industry; Wright described improving
efficiency of production in his 1930′s thesis as the skill
of the workers increased [14]. While this concept is in-
tuitive now with UG-FNABs, the number of biopsies
needed to attain acceptable adequacy rates remains
poorly answered. A South Korean comparison of an “ex-
perienced” versus “less-experienced” radiologist sug-
gested no significant difference in adequacy rates to
achieve 94 % [15]. However, not only had their experi-
enced radiologist performed over 12,000 biopsies, their
less experienced one had already performed at least 500.
Mahoney reported astounding inadequacy rates of 0.4 %
of thyroid biopsies, but admitted that they were within a
3-year interval after 15 years of experience [16].
In our assessment of learning curve, we analyzed ad-
equacy within each calendar year, which resulted in a
meaningful comparison. Published descriptions of UG-
FNAB learning curve involve setting 100 patients [17],
and similar case numbers have been described for the
learning curve of other medical procedures. Surgical pro-
cedures are somewhat different, and many authors de-
scribe somewhere between 20 and 50 cases to achieve
competency [18]. CT-guided FNA has been suggested to
have a learning curve of only 40 cases, with DelGaudio
reporting an improvement from 80 to 94 % adequacy [19].
A large proportion of the nodules biopsied had some
portion of cystic content within them. The American
Thyroid Association guidelines suggest that there is no
indication for the biopsy of purely cystic nodules. In our
series, forty-five of the non-diagnostic specimens con-
tained large cyst content. Some purely cystic nodules
were aspirated for causing compression symptoms
causing an overall adequacy rate for nodules described
as cystic of 65.9 %. These aspirates recorded as cystic in-
clude large spongiform nodules, and so all were included
in our non-diagnostic category. Controversy exists as to
whether cystic content should be placed into a separate
category on its own. In our study, cystic lesions were
seen to more likely yield non-diagnostic results, likely
because they have little to no follicular cells necessary
for diagnosis. This relationship can help to explain why
we have a less than perfect adequacy rate with UG-FNAB,
even after a physician achieves expertise. Additionally,
nodules with microcalcifications were more frequently
observed in specimens that were diagnostic. Since the
presence of microcalcifications is associated with pap-
illary thyroid carcinoma, the above relationship rein-
forces that malignant nodules are generally being
captured by UG-FNAB.
Once an audit of practice is performed, the next ques-
tion becomes how to improve quality. One method is to
standardize the procedure, with which some authors
have reported success [7]. Sidiropoulous reported im-
proved adequacy following standardization of technique
(needle size and number of passes), preparation of sam-
ples including both slide prep and liquid preparation
(which is quite time consuming), and personnel (difficult
in a teaching institution where residents and fellows are
involved). There is further evidence that standardizing



















Fig. 4 Eventual adequacy rate over time of all UG-FNABs divided by year. This double bar graph represents the breakdown of patients who eventually
received a diagnostic UG-FNAB, regardless of the number of biopsies, and those who never had a diagnostic UG-FNAB. The 289 patients were divided into the
years they received their biopsy; with 17 diagnostic and 7 non-diagnostic in 2010; 47 diagnostic and 12 non-diagnostic in 2011; 56 diagnostic and 6
non-diagnostic in 2012; 30 diagnostic and 5 non-diagnostic in 2013; 35 diagnostic and 4 non-diagnostic in 2014; and 66 diagnostic and 4 non-diagnostic
in 2015
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showed inadequacy rates of 33.8 %, 23.4 %, and 13.7 %
with 1, 2 and 3 needle passes respectively.
The utilization of on-site cytopathology is the subject
of controversy in the literature. Reports with on-site
evaluation approach 95 % [20, 21]. Some comparisons
report increase in diagnostic rates from 73 % to over
90 % [22] once the process is implemented. Olson
showed that both cytopathologists and less expensive
technologists are able to achieve similar levels of on-site
evaluation of adequacy [23]. The issue of course with
implementation is cost. Eedes calculated that in Boston,
the cytopathologist would spend 220 min of time for
each additional diagnostic case [24]. Zanocco performed
a formal cost-effectiveness analysis using a decision
model to compare strategies in the U.S. health system.
He found that when the adequacy rate without on-site
evaluation is less than 85 %, on-site evaluation became
cost-effective [25].
This review has several limitations owing to design.
Without prospectively collected data, factors such as
surgical technique, amount of passes, and recording of
nodule characteristics on ultrasound reports will be vari-
able. One of the main challenges faced was the lack of
consistent reporting of characteristics, which made ana-
lysis difficult. We did not have consistent data regarding
the specific indication for biopsy. Future audits will in-
clude prospectively collected data using standardized
forms. Although complications were not specifically re-
corded in this database, to the author’s knowledge there
were no complications.
Conclusion
Analysis of nodules’ characteristics revealed that cystic
lesions are more likely to yield non-diagnostic sampling,
which can help to explain why we have a less than per-
fect adequacy rate with UG-FNAB, even after a phys-
ician achieves expertise. However, this report ultimately
concluded that surgeon performed ultrasound guided
FNA of the thyroid is a useful tool that can be imple-
mented in the head and neck surgeon’s office with ease.
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